Toxicity evaluation and reporting are critical components of pharmaceutical development and regulatory submissions, ensuring patient safety, regulatory compliance, and risk-based decision-making. Our Toxicity Evaluation & Reporting services support pharmaceutical and life sciences organizations with scientifically robust, regulator-accepted toxicological assessments aligned with global regulatory expectations.
We provide comprehensive toxicological risk assessments and regulatory-ready reports to support DMF submissions, eCTD dossiers, EDQM filings, and emerging market registrations.
Comprehensive Toxicity Evaluation Services
Our services cover the complete toxicological assessment lifecycle, from data evaluation to regulatory reporting and submission support.
Scope of Toxicity Evaluation & Reporting
- Nonclinical & Toxicological Risk Assessment
- Evaluation of toxicological profiles of APIs, excipients, and impurities
- Identification of toxicological concerns and safety risks
- Assessment of exposure limits and safety margins
- Risk classification based on intended use and dosage
- Impurity & Genotoxicity Assessment
- Toxicological evaluation of process- and degradation-related impurities
- Genotoxic impurity (GTI) assessment
- Justification of acceptable intake limits
- Control strategy support for regulatory compliance
- Elemental Impurities & Residual Solvents
- Toxicity assessment of elemental impurities
- Permitted daily exposure (PDE) justification
- Residual solvent classification and toxicological evaluation
- Risk-based control and mitigation strategies
- Extractables & Leachables (E&L)
- Toxicological evaluation of extractables and leachables
- Patient safety impact assessment
- Justification of safety thresholds
- Regulatory reporting support
- Occupational & Environmental Toxicity (as applicable)
- Occupational exposure limit (OEL) assessment support
- Environmental risk assessment (ERA) inputs
- Safety handling and control recommendations
Regulatory Standards & Guidelines Covered
Our toxicity evaluation and reporting services align with:
- ICH Q3A, Q3B, Q3C, Q3D
- ICH M7 (Genotoxic Impurities)
- ICH S-series (Nonclinical Safety)
- US FDA, EMA & EDQM Guidelines
- WHO-GMP & Global Regulatory Expectations
This ensures acceptability across US, EU, and emerging market submissions.
Risk-Based & Science-Driven Approach
We apply a science-driven, risk-based toxicological assessment methodology, focusing on patient safety, product quality, and regulatory acceptance. Our approach ensures clarity, traceability, and defensible conclusions during regulatory review.
Key Deliverables
- Comprehensive toxicological risk assessment reports
- Impurity and genotoxicity justification reports
- PDE and acceptable intake calculations
- Regulatory-ready toxicology summaries
- Support for regulatory queries and deficiencies
Why Choose Our Toxicity Evaluation & Reporting Services?
- Experienced Toxicology Expertise
Regulatory-aligned assessments with scientific rigor. - Submission-Ready Documentation
Reports structured for DMF, eCTD, and EDQM filings. - Risk-Based & Defensible Conclusions
Clear justifications accepted by global regulators. - Integrated Regulatory Support
Seamless coordination with DMF, eCTD, and compliance teams. - Confidential & Secure Data Handling
Protection of sensitive product and process data.
Industries We Support
- API Manufacturers
- Pharmaceutical Formulation Manufacturers
- Excipient Manufacturers
- Contract Manufacturing Organizations (CMOs)
- Export-Oriented Pharmaceutical Companies
- Product Development & R&D Organizations
Ensure Safety. Strengthen Submissions. Succeed Globally.
With increasing regulatory focus on impurity control, genotoxicity, and patient safety, robust Toxicity Evaluation & Reporting is essential for successful regulatory approvals. Our structured, regulator-aligned approach helps ensure scientific credibility, regulatory acceptance, and inspection readiness.
